NCT05152576View on ClinicalTrials.gov

A Study To Assess the Adverse Effects and Change in Condition of OnabotulinumtoxinA X Injection in Adult Participants With Forehead Lines

PHASE2CompletedINTERVENTIONAL
Enrollment

124

Participants

Timeline

Start Date

November 29, 2021

Primary Completion Date

September 6, 2022

Study Completion Date

September 6, 2022

Conditions
Forehead Lines
Interventions
DRUG

OnabotulinumtoxinA X

Intramuscular Injection

DRUG

Placebo

Intramuscular Injection

Trial Locations (8)

14623

Skin Search of Rochester Inc. /ID# 239773, Rochester

27262

Dermatology Consulting Service /ID# 239779, High Point

28403

Wilmington Dermatology Center /ID# 239778, Wilmington

75231

Dallas Plastic Surgery Institute /ID# 239777, Dallas

78660

Duplicate_Austin Institute for Clinical Research /ID# 239783, Pflugerville

92663

Steve Yoelin MD Medical Associate Inc /ID# 239771, Newport Beach

92663-3637

The Eye Research Foundation /ID# 241512, Newport Beach

10549-3028

The Center for Dermatology Cosmetics & Laser Surgery /ID# 239776, Mount Kisco

Sponsors

Lead Sponsor

Allergan
All Listed Sponsors
lead

Allergan

INDUSTRY